Pay attention to the research on the mechanism of retinoblastoma and the methods of diagnosis and treatment / 中华眼底病杂志
Chinese Journal of Ocular Fundus Diseases
; (6): 173-177, 2022.
Article
en Zh
| WPRIM
| ID: wpr-934289
Biblioteca responsable:
WPRO
ABSTRACT
Retinoblastoma (RB) is the most serious eye disease that causes blindness, disability and death in infant. Loss of tumor suppressor gene RB1 leads to tumorigenesis of RB. With continuous innovation and development of new methods, the management of retinoblastoma has experienced a dramatic change from enucleation, external radiotherapy, intravenous chemotherapy, to intra-arterial chemotherapy combined with local treatment, enabling a more favorable outcome for survival, salvage and vision. However, the pathogenesis of RB is unclear in many aspects, the rate of eyeball removal in children with advanced RB remains high, and the innovation of new treatment are needed to be further promoted. Therefore, the key to improve the overall treatment level of RB is to pay attention to the study on pathogenesis, early diagnosis and treatment, as well as strengthen multi-center clinical trials and translational medicine research.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Screening_studies
Idioma:
Zh
Revista:
Chinese Journal of Ocular Fundus Diseases
Año:
2022
Tipo del documento:
Article